Project Oncology®

177 Episoder

1. FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer

   Publisert: 7.1.2018
2. CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer

   Publisert: 23.10.2017
3. Pancreatic Cancer: The Hunt to Catch a Silent Killer

   Publisert: 12.8.2017
4. FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer

   Publisert: 28.7.2017
5. FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer

   Publisert: 25.7.2017
6. Linking p53 Variation to Breast Cancer Risk in African American Women

   Publisert: 19.6.2017
7. FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval

   Publisert: 30.5.2017
8. Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches

   Publisert: 23.5.2017
9. FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma

   Publisert: 22.5.2017
10. FDA D.I.S.C.O.: Niraparib in Ovarian Cancer

    Publisert: 18.5.2017
11. Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer

    Publisert: 17.4.2017
12. Hot Topics in Breast Cancer Innovations

    Publisert: 6.2.2017
13. A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient

    Publisert: 2.2.2017
14. High Hopes for Cannabis in Oncology: Therapeutic Applications Beyond Pain Management

    Publisert: 20.4.2016
15. From Silent Killer to Treatable Disease: Improved Detection Methods for Ovarian Cancer

    Publisert: 7.3.2016
16. Are Practicing Ob-Gyn Oncologists on Your Speed Dial?

    Publisert: 8.2.2016
17. Nutrition & Breast Cancer Risk: Connecting the Dots with Emerging Evidence

    Publisert: 31.8.2015